Work

Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study

Year: 2026

Type: article

Study design: Observational Study

Source: Journal of Oncology Pharmacy Practice

DOI: 10.1177/10781552251412298

Authors: Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan, Furkan Bahar, Çağrı Belli, Damla Ortaboz, Tuğrul Elverdi, Ayşe Salihoğlu, Muhlis Cem Ar, Zafer Başlar, Ahmet Emre Eşkazan

Institutions: Eskişehir City Hospital, Sağlık Bilimleri Üniversitesi, Gazi University, Mount Auburn Hospital, Harvard University, Acıbadem University, Istanbul University-Cerrahpaşa

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7118921417

FWCI:

Cites: 16

Cited by:

Related to: